137 related articles for article (PubMed ID: 10881892)
21. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.
Molano M; Van den Brule A; Plummer M; Weiderpass E; Posso H; Arslan A; Meijer CJ; Muñoz N; Franceschi S;
Am J Epidemiol; 2003 Sep; 158(5):486-94. PubMed ID: 12936904
[TBL] [Abstract][Full Text] [Related]
22. Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.
Winer RL; Xi LF; Shen Z; Stern JE; Newman L; Feng Q; Hughes JP; Koutsky LA
Int J Cancer; 2014 Apr; 134(8):1889-98. PubMed ID: 24136492
[TBL] [Abstract][Full Text] [Related]
23. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
Riethmuller D; Gay C; Bertrand X; Bettinger D; Schaal JP; Carbillet JP; Lassabe C; Arveux P; Seilles E; Mougin C
Diagn Mol Pathol; 1999 Sep; 8(3):157-64. PubMed ID: 10565688
[TBL] [Abstract][Full Text] [Related]
24. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma.
Chua KL; Hjerpe A
Cancer; 1996 Jan; 77(1):121-7. PubMed ID: 8630917
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage.
Wang M; Hou B; Wang X; Han L; Shi Y; Zhang Y; Zhang L; Liu L; Jin F; Zhang Y
Cancer Med; 2021 Apr; 10(7):2482-2488. PubMed ID: 33682355
[TBL] [Abstract][Full Text] [Related]
27. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
28. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
29. Cervical human papillomavirus screening among older women.
Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D
Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718
[TBL] [Abstract][Full Text] [Related]
30. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus prevalence, viral load and cervical intraepithelial neoplasia in HIV-infected women.
Levi JE; Fink MC; Canto CL; Carretiero N; Matsubara R; Linhares I; Das Dores GB; Castelo A; Segurado A; Uip DE; Eluf J J
Braz J Infect Dis; 2002 Jun; 6(3):129-35. PubMed ID: 12144749
[TBL] [Abstract][Full Text] [Related]
32. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.
Jacobs MV; Walboomers JM; Snijders PJ; Voorhorst FJ; Verheijen RH; Fransen-Daalmeijer N; Meijer CJ
Int J Cancer; 2000 Jul; 87(2):221-7. PubMed ID: 10861478
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus and invasive cervical cancer in Brazil.
Eluf-Neto J; Booth M; Muñoz N; Bosch FX; Meijer CJ; Walboomers JM
Br J Cancer; 1994 Jan; 69(1):114-9. PubMed ID: 8286192
[TBL] [Abstract][Full Text] [Related]
34. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer.
Chen HC; Schiffman M; Lin CY; Pan MH; You SL; Chuang LC; Hsieh CY; Liaw KL; Hsing AW; Chen CJ;
J Natl Cancer Inst; 2011 Sep; 103(18):1387-96. PubMed ID: 21900119
[TBL] [Abstract][Full Text] [Related]
35. Chlamydia trachomatis infection and persistence of human papillomavirus.
Silins I; Ryd W; Strand A; Wadell G; Törnberg S; Hansson BG; Wang X; Arnheim L; Dahl V; Bremell D; Persson K; Dillner J; Rylander E
Int J Cancer; 2005 Aug; 116(1):110-5. PubMed ID: 15756673
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.
Ramanakumar AV; Goncalves O; Richardson H; Tellier P; Ferenczy A; Coutlée F; Franco EL
BMC Infect Dis; 2010 Nov; 10():326. PubMed ID: 21070660
[TBL] [Abstract][Full Text] [Related]
37. Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
Lorincz AT; Castle PE; Sherman ME; Scott DR; Glass AG; Wacholder S; Rush BB; Gravitt PE; Schussler JE; Schiffman M
Lancet; 2002 Jul; 360(9328):228-9. PubMed ID: 12133661
[TBL] [Abstract][Full Text] [Related]
38. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma.
Moberg M; Gustavsson I; Wilander E; Gyllensten U
Br J Cancer; 2005 Mar; 92(5):891-4. PubMed ID: 15756259
[TBL] [Abstract][Full Text] [Related]
39. Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women.
Mbulawa ZZ; Johnson LF; Marais DJ; Gustavsson I; Moodley JR; Coetzee D; Gyllensten U; Williamson AL
BMC Infect Dis; 2014 Jan; 14():51. PubMed ID: 24484380
[TBL] [Abstract][Full Text] [Related]
40. Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study.
Soto-De León SC; Del Río-Ospina L; Camargo M; Sánchez R; Moreno-Pérez DA; Pérez-Prados A; Patarroyo ME; Patarroyo MA
BMC Infect Dis; 2014 Jul; 14():395. PubMed ID: 25030273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
